Cargando…

Pharmacological Treatments against COVID-19 in Pregnant Women

The recent respiratory virus known as SARS-CoV-2 has caused millions of deaths worldwide, causing great uncertainty due to the lack of a specific treatment, which has been mitigated by the use of various drugs traditionally used against other types of pathologies. Pregnancy presents special physiolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Arco-Torres, Ana, Cortés-Martín, Jonathan, Tovar-Gálvez, María Isabel, Montiel-Troya, María, Riquelme-Gallego, Blanca, Rodríguez-Blanque, Raquel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584594/
https://www.ncbi.nlm.nih.gov/pubmed/34768416
http://dx.doi.org/10.3390/jcm10214896
_version_ 1784597487230648320
author Arco-Torres, Ana
Cortés-Martín, Jonathan
Tovar-Gálvez, María Isabel
Montiel-Troya, María
Riquelme-Gallego, Blanca
Rodríguez-Blanque, Raquel
author_facet Arco-Torres, Ana
Cortés-Martín, Jonathan
Tovar-Gálvez, María Isabel
Montiel-Troya, María
Riquelme-Gallego, Blanca
Rodríguez-Blanque, Raquel
author_sort Arco-Torres, Ana
collection PubMed
description The recent respiratory virus known as SARS-CoV-2 has caused millions of deaths worldwide, causing great uncertainty due to the lack of a specific treatment, which has been mitigated by the use of various drugs traditionally used against other types of pathologies. Pregnancy presents special physiological conditions that expose the pregnant woman and the foetus to greater risk. Pregnant women are often excluded from trials due to possible risk of toxicity or side effects, resulting in a lack of knowledge about the use of drugs and treatments during pregnancy. The main objective of this review was to compile existing knowledge about currently available drug treatments for COVID-19 in pregnant women. The review report met the criteria of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) review protocol and was registered with the registration number CRD42021251036. The electronic databases searched were Scopus, PubMed, CINAHL and SciELO. Finally, 22 articles were included, resulting in an analysis of drugs with an acceptable safety profile in the treatment of pregnant women with COVID-19.
format Online
Article
Text
id pubmed-8584594
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85845942021-11-12 Pharmacological Treatments against COVID-19 in Pregnant Women Arco-Torres, Ana Cortés-Martín, Jonathan Tovar-Gálvez, María Isabel Montiel-Troya, María Riquelme-Gallego, Blanca Rodríguez-Blanque, Raquel J Clin Med Review The recent respiratory virus known as SARS-CoV-2 has caused millions of deaths worldwide, causing great uncertainty due to the lack of a specific treatment, which has been mitigated by the use of various drugs traditionally used against other types of pathologies. Pregnancy presents special physiological conditions that expose the pregnant woman and the foetus to greater risk. Pregnant women are often excluded from trials due to possible risk of toxicity or side effects, resulting in a lack of knowledge about the use of drugs and treatments during pregnancy. The main objective of this review was to compile existing knowledge about currently available drug treatments for COVID-19 in pregnant women. The review report met the criteria of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) review protocol and was registered with the registration number CRD42021251036. The electronic databases searched were Scopus, PubMed, CINAHL and SciELO. Finally, 22 articles were included, resulting in an analysis of drugs with an acceptable safety profile in the treatment of pregnant women with COVID-19. MDPI 2021-10-24 /pmc/articles/PMC8584594/ /pubmed/34768416 http://dx.doi.org/10.3390/jcm10214896 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Arco-Torres, Ana
Cortés-Martín, Jonathan
Tovar-Gálvez, María Isabel
Montiel-Troya, María
Riquelme-Gallego, Blanca
Rodríguez-Blanque, Raquel
Pharmacological Treatments against COVID-19 in Pregnant Women
title Pharmacological Treatments against COVID-19 in Pregnant Women
title_full Pharmacological Treatments against COVID-19 in Pregnant Women
title_fullStr Pharmacological Treatments against COVID-19 in Pregnant Women
title_full_unstemmed Pharmacological Treatments against COVID-19 in Pregnant Women
title_short Pharmacological Treatments against COVID-19 in Pregnant Women
title_sort pharmacological treatments against covid-19 in pregnant women
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584594/
https://www.ncbi.nlm.nih.gov/pubmed/34768416
http://dx.doi.org/10.3390/jcm10214896
work_keys_str_mv AT arcotorresana pharmacologicaltreatmentsagainstcovid19inpregnantwomen
AT cortesmartinjonathan pharmacologicaltreatmentsagainstcovid19inpregnantwomen
AT tovargalvezmariaisabel pharmacologicaltreatmentsagainstcovid19inpregnantwomen
AT montieltroyamaria pharmacologicaltreatmentsagainstcovid19inpregnantwomen
AT riquelmegallegoblanca pharmacologicaltreatmentsagainstcovid19inpregnantwomen
AT rodriguezblanqueraquel pharmacologicaltreatmentsagainstcovid19inpregnantwomen